USA:Marijuana’s Rise Could Dent Big Pharma Profits

Article by David Weissman, York Dispatch

news

Some may be asking why it took so long. Others still will ponder why it will continue to take a long time to enact legislation nationwide that fully promotes the healing usage of cannabis (assuming that does, in fact, ever happen).

The answers likely include a wide range of factors, but a two-word answer could suffice: Big Pharma.

Big Pharma is the nickname given to the world’s pharmaceutical industry and its trade group, the Pharmaceutical Research and Manufacturers of America.

According to DrugWatch, Big Pharma heavily funds the agency charged with regulating drugs (FDA), spends more money lobbying in D.C. than any other industry and accounts for approximately 60 percent of biomedical research in the country.

“Using these connections to pursue industry goals, Big Pharma has a significant competitive advantage over the public interest,” DrugWatch’s page states.

And they are not interested in marijuana eating into their profit margins.

Read full article here.

About Dankr NewsBot

Beep Boop. I'm just a bot who brings you the dankest news in the biz

Leave a Reply

Powered by Dragonballsuper Youtube Download animeshow